EGETIS THERAPEUTICS AB NPV financial statements, including revenue, expenses, profit, and loss
The total revenue of 0ABW for the last quarter is 12.10 M SEK, and it's 62.88% lower compared to the previous quarter. The net income of Q1 24 is -75.00 M SEK.